Many cancer patients with type 2 diabetes has metabolic and hormonal characteristics and the hyperproliferative processes of cancer cells could be suppressed by metformin or dietary protein restriction through insulin-independent and insulin-dependent mechanisms[35,36]. The gene discussed is INS; the disease is type 2 diabetes mellitus.